The latest closing stock price for Cullinan Therapeutics as of January 31, 2025 is 10.56.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-647 today, roughly -1 times their original investment - a -22.92% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 185.9% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 9.50, which is 10% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 17.17.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-647 today, roughly -1 times their original investment - a -22.92% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 185.9% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 9.50, which is 10% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 17.17.